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Background: Drug-using offenders with co-occurring mental health problems are common in the criminal justice
system. A combination of drug use and mental health problems makes people more likely to be arrested for criminal
involvement after release compared to offenders without a mental health problem. Previous research has evaluated
interventions aimed broadly at those with a drug problem but rarely with drug use and mental health problems. This
systematic review considers the effectiveness of interventions for drug-using offenders with co-occurring mental health
problems.
Methods: We searched 14 electronic bibliographic databases up to May 2014 and five Internet resources. The review
included randomised controlled trials designed to reduce, eliminate, or prevent relapse of drug use and/or criminal
activity. Data were reported on drug and crime outcomes, the identification of mental health problems, diagnoses and
resource information using the Drummond checklist. The systematic review used standard methodological procedures
as prescribed by the Cochrane collaboration.
Results: Eight trials with 2058 participants met the inclusion criteria. These evaluated: case management (RR, 1.05, 95 %
CI 0.90 to 1.22, 235 participants), motivational interviewing and cognitive skills, (MD-7.42, 95 % CI-0.20.12 to 5.28, 162
participants) and interpersonal psychotherapy (RR 0.67, 95 % CI 0.3 to 1.5, 38 participants). None of these trials reported
significant reductions in self-report drug misuse or crime. Four trials evaluating differing therapeutic community
models showed reductions in re-incarceration (RR 0.28, 95 % CI 0.13 to 0.63, 139 participants) but not re-arrest (RR 1.65,
95 % CI 0.83 to 3.28, 370 participants) or self-report drug use (RR 0.73, 95 % CI 0.53 to 1.01, 370 participants). Mental
health problems were identified across the eight trials and 17 different diagnoses were described. Two trials reported
some resource information suggesting a cost-beneficial saving when comparing therapeutic communities to a prison
alternative.
Conclusions: Overall, the studies showed a high degree of variation, warranting a degree of caution in the
interpretation of the magnitude of effect and direction of benefit for treatment outcomes. Specifically, tailored
interventions are required to assess the effectiveness of interventions for drug-using offenders with co-occurring
mental health problems.
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This systematic review stems from a previous Cochrane
review which evaluated the effectiveness of interventions
for drug using offenders (anonymised author and web
link). The original Cochrane review was updated to pro-
duce three further reviews which explored the effective-
ness of interventions aimed at reducing drug use and
criminal activity in, i) drug using female offenders
(Perry et al. 2015b), ii) drug using offenders with co-
occurring mental health problems (Perry et al. 2015a),
iii) pharmacological interventions (Perry et al. 2015c)
and iv) non-pharmacological interventions (Perry et al. in
press). This paper summarises the review findings of
offenders with co-occurring mental health problems
and in addition reports on mental health outcomes
and diagnoses.Background literature
Mental health issues in offenders are common with over
half (64 %) of jail inmates in the US reporting a serious
mental health problem (Cosden et al. 2003; Glaze and
James 2006; Johnson and Zlotnick 2012; Stein et al.
2011). Such problems are more apparent in women
(31 %) than men (14.5 %). A systematic review of 62 sur-
veys found that prisoners were several times more likely
to have a diagnoses of psychosis or major depression
and ten times more likely to have an antisocial personal-
ity disorder than the general population (Fazel and
Danesh 2002).
The provision of mental health care in US jails was
found to be poor with most providing only intake
screening, mental health evaluations and suicidal pre-
vention services (Steadman and Veysey 1997). In
addition, the evidence suggests that people who suffer
from a mental health problems are disproportionately
more likely to be arrested when compared with of-
fenders without mental health problems (Lamb and
Weinberger 1998; Lovell et al. 2002). Reasons for this in-
clude limited support in the community, poor co-
ordination of services and treatment on release, prob-
lems accessing treatment, and police and societal atti-
tudes (Cloyes et al. 2010).
Large numbers of offenders also suffer from substance
misuse problems and have been consistently reported as
a major contributing factor in the increasing population
of women offenders (Greenfeld and Snell 1999; Staton-
Tindall et al. 2007). The relationship between drugs and
crime is also complex. The literature has discussed the
issue of whether drug use leads people into criminal ac-
tivity or whether those who use drugs are already predis-
posed to such activity. Whilst the majority of women
offenders have a history of drug use and drug-related of-
fenses the research evidence suggests that only a smallproportion of both men and women receive appropriate
treatment and supervision (Taxman 2002).
The combination of drug use and offending behaviour
has a substantial economic impact on society and specif-
ically on formal service resources (Byford et al. 2013). In
2011 the National Drug Intelligence Center [NDIC] esti-
mated that the cost to society of drug abuse was $193
billion. Of this they reported that $113 billion was asso-
ciated with drug related crime, including criminal justice
system costs and costs borne by victims of crime. They
argue that the cost of treating drug abuse (including
health costs, hospitalizations, and government specialty
treatment) was a fraction of the overall societal costs.
Treatment has also shown to reduce the costs associated
with lost productivity, crime, and incarceration across
various settings and populations. The largest economic
benefit of treatment is seen in avoided costs of crime
(incarceration and victimization costs).
Policy initiatives in the US and UK, show a renewed
recognition that the criminal justice system (CJS) is not
always the best place to manage people suffering from
mental health problems. In the case of less serious of-
fenders, several diversionary schemes have been estab-
lished to provide a mechanism for diverting individuals
with mental health problems into treatment programmes
instead, or combined with incarceration (Clarke 2010;
Sarteschi et al. 2011). Findings from such studies gener-
ally show positive improvements on a small number of
clinical outcomes. However, the certainty of any causal
link is often restricted by type of research design (i.e.,
quasi-experimental studies), which limit any conclusions
about their relative effectiveness (Campbell and Stanley
1963; Cook and Campbell 1979).
Evidence from previous systematic reviews have
tended to investigate the effectiveness of interventions
for either (i) drug using offenders, or (ii) offenders with
mental health problems. Evidence supporting the case
for treatment include a range of different treatment op-
tions. Some examples include case management, thera-
peutic community models, cognitive skills and
behavioural management and motivational interviewing.
Case management evolved to address the needs of pris-
oner re-entry programmes covering employment, educa-
tion, health, housing and family support via assessment
and connecting clients with the appropriate services
(Austin and McClelland 1996). Case management in the
US has been applied in Treatment Accountability for
Safer Communities (TASC) programmes (Marlowe et al.
2003), and has shown initial effectiveness but without
systematic evidence in support of the process.
Similar findings have been found when using
cognitive-behavioural approaches. Such programmes
tend to include a number of different techniques includ-
ing self-monitoring, goal setting, self-control training,
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work and lifestyle modification. These have also shown
signs of success with offenders in the general prison
population (Lipsey et al. 2007) but have excluded evalua-
tions of drug-using offenders with co-occurring mental
health problems (Andrews et al. 1990; Lipsey et al. 2007;
Lipsey and Wilson 1998). Acceptance and commitment
therapy (ACT) is an intervention in the form of CBT fo-
cussing on an individual accepting personal events ra-
ther than attempting to change them and addresses
goals for behaviour change. A recent meta-analysis
found ACT outperformed control, treatment as usual
and waitlist control conditions with individuals with
mental health problems in the general population (A-
Tjak et al. 2015).
Motivational Interviewing (MI) also has a proven the-
oretical background showing that such techniques can
lead to improved retention in treatment, enhanced mo-
tivation to change and reduced offending, (McMurran
2009; Smedslund et al. 2011). Miller and Rollnick (1991)
developed MI as a process to motivate change in sub-
stance abusers. The technique uses strategies to encour-
age expressing empathy, avoiding arguing for change
and working on ambivalence to strengthen commitment
to change. Meta-analyses evidence supports the use of
MI as a stand-alone treatment and in combination with
more intensive programmes (e.g., Vasilaki et al. (2006). A
similar approach used also with people suffering from
drug misuse (interpersonal psychotherapy: IPT) prob-
lems shows some success in reducing drug misuse with
non-criminal justice settings, (Johnson and Zlotnick
2012). IPT and MI are similar in approach with both fo-
cussing on building skills to deal with social situations
and conflict, as well as additional support for substance
use. MI was initially developed for substance abusers
with the main focus being client motivation to facilitate
change in health-related behaviours (Miller and Rollnick
1991). Whilst IPT was initially developed as a structured
therapy for people with depression, with the main focus
being the ability to understand psychological symptoms
as a response to everyday situations and difficulties (de
Mello et al. 2005).
Therapeutic communities (TCs) have been used in the
US since the 1960s and more recently in the UK to re-
habilitate offenders over a relatively long period of time.
The TC ethos focuses on treatment of the ‘whole self ’
and not on the drug abuse per se. Residents are instru-
mental in running the TC and supporting each other
through the process and this encompasses the transition
between prison and working within the community (e.g.,
(Mitchell et al. 2012; Prendergast et al. 2011). Evalua-
tions of TC interventions using previous meta-analyses
and systematic reviews show modest effects in the re-
duction of recidivism and drug use in male adultoffenders (e.g., (Mitchell et al. (2012); Pearson and Lip-
ton 1999); but have not focused on the co-occurrence
between drug misuse and mental health problems and
previous evaluations. Therapeutic communities can be
tailored to meet the needs of specific groups. Personal
reflections is an example of a modified TC treatment,
which involves the inclusion of a cognitive behavioural
element for individuals with mental health problems and
substance use disorders (Sacks et al. 2004).
We found one previous systematic review of 16 rando-
mised controlled trials (RCTs) comprising adult of-
fenders with mental health problems. The findings
showed that clozapine was favoured over alternative
treatments for improving psychiatric symptoms. The re-
view identified limited evidence to show that discharge
planning with benefit application assistance and the use
of mental health services on release from incarceration
was effective. The authors called for more comparative
trials to increase their confidence in the findings (Fonta-
narosa et al. 2013). Other systematic reviews have evalu-
ated interventions and conducted meta-analyses based
on single treatment components (Martin et al. 2012;
Morgan et al. 2012). Two reviews focused purely on
pharmacological treatments (Griffiths et al. 2012;
Huband et al. 2010).
The previous evidence demonstrates varied success
with reductions in mental health, crime and drug out-
comes but we know little about how interventions for
drug using offenders and co-occurring mental health
problems can help address treatment and rehabilitation
opportunities. For this reason, we believe a systematic
evaluation of the existing evidence might help add to the
current body of evidence by identifying specific interven-
tions for this group of people. We are also interested in
learning more about how such individuals are identified,
what diagnoses they are given and how much such inter-
ventions might cost. The review was therefore broad and
included any intervention that was designed to reduce,
eliminate or prevent relapse to drug use and/or criminal
activity in a sample of participants with drug misuse
problems and mental health diagnoses. The review ad-
dressed the following questions: (1) Does any treatment
for drug-using offenders with co-occurring mental
health problems reduce drug use? (2) Does any treat-
ment for drug-using offenders with co-occurring mental
health problems reduce criminal activity? (3) How are
people identified and diagnosed of a mental health prob-
lem? (4) Is there any resource information to enable a
cost evaluation?
Methods
Search strategy for identification of studies
This review stems from an original Cochrane review (in-
sert anonymised reference). The results of this update
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review finished (insert anonymous reference). We
searched 14 databases and identified records between
2004 and May 2014.1 Specified search strategies were
developed for each database to include randomised con-
trolled trials (RCTs) of any language. For this purpose,
filters retrieved from the Inter TASC Information Spe-
cialists’ Sub-Group (ISSG) Search Filter Resource Site
(www.york.ac.uk/inst/crd/intertasc/) were used. The fol-
lowing are examples of the search terms used in the
searches; prison, offender, substance or drug and re-
offend. The search terms and strategies are documented
in full in the following publication, (insert anonymised
reference).
In addition to the electronic databases, we searched
relevant Internet sites (e.g., Home Office, National Insti-
tute of Drug Abuse (NIDA)) and we scrutinised the ref-
erence lists of all retrieved articles for further references.
We undertook catalogue searches of relevant organisa-
tions and contacted experts for their knowledge of other
published or unpublished studies relevant to the review.Study design
The review included RCTs whereby the intervention was
designed to reduce, eliminate, or prevent relapse of drug
use and/or criminal activity. The comparison arm could
contain no treatment, minimal treatment, a waiting list,
treatment as usual or another treatment alternative.Selection of participants
We included drug-using offenders with co-occurring
mental health problems regardless of gender, age or eth-
nicity. Drug misuse included any study that referred to
individuals using occasional drugs or were drug
dependent. We defined offenders as individuals who
were involved in the CJS as residing in special hospitals,
prisons, community diversion into court schemes or
placed on arrest referral schemes for treatment. Of-
fenders were judged to have a co-occurring mental
health problem if the mechanism of identification was
explicitly stated in the paper. The mechanism could in-
clude one or more of the following methods: i) use of
diagnostic gold standard test (e.g., the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV)), and/or ii) whereby the nature of the inter-
vention was specifically designed for people with mental
health problems (e.g., mental health court), and/ or iii)
the participants were described as having a ‘history of
psychiatric illness’ or a ‘serious mental disorder’ with co-
occurrence of drug use. In some cases, this information
was obtained from the participant description and
demographic characteristics.Types of interventions
The interventions were designed, wholly or in part, to
eliminate or prevent relapse to drug-use and/or criminal
activity among participants. Based on these criteria we
included a number of different psychosocial interven-
tions. Psychosocial interventions have been defined as
any intervention that focuses on social or psychological
factors rather than biological factors (Ruddy and House
2005).
Primary outcomes
Two primary outcomes (drug misuse and criminal activ-
ity) were reported as dichotomous and continuous out-
come measures. Drug use measures were reported as:
(1) self-report drug use (including unspecified drug, spe-
cific drug use not including alcohol, and Addiction Se-
verity Index Drug Composite Scores); and (2) biological
drug use (measured by drug testing by either urine or
hair analysis). Criminal activity measures were reported
using self-report or official criminal justice records.
These included arrest for any offence, drug offences, re-
incarceration, convictions, charges and recidivism.
Where papers evaluated a number of different follow-up
periods, we chose to report the longest follow up period
as we felt that such measures provided the most conser-
vative estimate of effectiveness.
Secondary outcomes
Mental health diagnoses and identification
Mental health diagnoses were taken from participant
sample descriptions about how people were identified to
take part within the trial. For this purpose, we used diag-
nostic gold standard test evidence, the nature of the
intervention and demographic and background charac-
teristics of the persons included.
Resource information
Resource information was examined with a full critical
appraisal using the (Drummond et al. 1997) checklist.
According to Drummond studies containing information
on the economics on the intervention are defined as full
economic evaluation studies, partial economic evalu-
ation studies, and single effectiveness studies (see
Table 1). Full economic evaluations are the comparative
analysis of alternative courses of action in terms of both
costs (resource use) and consequences (outcomes, ef-
fects: (Drummond et al. 1997). This differs from studies
which focus solely on costs and resource use, or partial
economic evaluations. Studies that use a full economic
evaluation do not generally use a single research
method; and aim to describe, measure and value all rele-
vant alternative courses of action (e.g. intervention X
versus comparator Y), their resource inputs and conse-
quences, are referred to as a Cost-benefit analysis
Table 1 Classification scheme for economic evaluations (Drummond 2005)
Are both costs (inputs) and consequences (outputs) of the alternative examined?
Are two or more alternatives compared? No No Yes
Examine consequences only Examine only costs
1B PARTIAL EVALUATION 1B 2 PARTIAL EVALUATION
Outcome Description Cost description Cost-outcome description
Yes 3A PARTIAL EVALUATION 3B 4 FULL ECONOMIC EVALUATION
Efficacy effectiveness evaluation (e.g., RCT) Cost analysis Cost effectiveness analysis
Cost Utility analysis
Cost benefit analysis
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95 % confidence
interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95 % CI)
CI confidence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate
Very low quality: We are very uncertain about the estimate
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count all consequences include cost-effectiveness ana-
lysis (CEA) and cost-utility analysis (CUA). According to
Drummond evaluations need to be comparative as an
intervention can only be labelled relative to a benchmark
or alternative. Evaluations that are not comparative and
do not consider both costs and consequences, and/or a
comparator is classified as a partial evaluation (e.g., 1A,
1B, 2). A cost effectiveness or cost study is described if
alternatives are compared (e.g., 3A, 3B). However, if only
the costs or benefits are described the evaluation is still
considered partial evaluation but would be comparative
across one-dimension. A study evaluating all aspects of
the economic dimensions and a comparative would be
considered a full economic costing (e.g. 4).
Data collection and analysis
The studies were identified using a number of stages. At
each stage two reviewers were involved. The stages in-
cluded i) independently inspecting the search hits by
reading the titles and abstracts in a bibliographic data-
base, ii) obtaining a full copy of each potentially relevant
study, iii) assessing each study for inclusion, and iv) in-
dependently conducting a data extraction and agreement
process. In the case of discordance, a third independent
reviewer arbitrated. One reviewer undertook all the
above stages in the translation of articles that were not
written in English. The data extraction was completed
using a standardised reporting system and a range of
items coded (e.g., information about the study sample,
intervention and control group and the key results for
our outcome measures). We also grouped the studies by
intervention type and setting creating four intervention
groups: case management, motivational interviewing and
cognitive skills, interpersonal therapy and therapeutic
community models.Statistical methods
We conducted a narrative presentation of the study de-
tails (e.g., author, year of publication and country of
study origin), study methods (e.g. random assignment),
participants (e.g., number in sample, age, gender, ethni-
city, age, mental health status), interventions (e.g., de-
scription, duration, intensity and setting), outcomes (e.g.,
description, follow-up period and reporting mechanism),
resource information (e.g., number of staff, intervention
delivery, estimated costs and estimated savings) and
made notes on the study methodology and quality ap-
praisal information using the Cochrane risk of bias tool.
We were able to standardize our outcome measures
using a mean difference (MD) for continuous outcomes
measured on the same scale and a standardized mean
difference (SMD) for outcomes measured on different
scales. Higher scores for continuous measures repre-
sented greater harm. We risk ratios (RR) for dichotom-
ous outcomes, and all were presented with 95 %
confidence intervals (CIs).
To avoid double counting of our outcome measures
(e.g., arrest and parole violation) and follow up time pe-
riods (e.g., 12, 18 months) all trials were checked to en-
sure that multiple studies reporting the same evaluation
did not contribute towards multiple estimates of pro-
gram effectiveness. We followed Cochrane Collaboration
guidance and combined intervention and control groups
to create single pair wise comparisons. Where this was
not appropriate we selected one treatment arm and ex-
cluded the others see (Higgins and Green 2011).
Presentation of study quality and effectiveness
We used Summary of Findings Tables (SoF Table) to
provide a concise and transparent summary of the key
findings on the quality and certainty of the evidence
using GRADE PRO software (Vandvik et al. 2012). The
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Working Group and adopted by the Cochrane Collabor-
ation (Guyatt et al. 2008). The assessment includes an
evaluation of the confidence (quality of evidence) and
magnitude of effects. A typical table included (i) the pri-
mary outcome measures, (ii) a measure of the burden of
these outcomes for the control group risk, and the inter-
vention group, (iii) the relative magnitude of effect, (iv)
the numbers of participants and studies addressing these
outcomes, and (v) a rating of overall confidence in effect
estimates for each outcome (Langendam et al. 2013).
The quality of the evidence assesses the extent to
which we can be confident that the estimates of effect
are correct. These judgements are made using the
GRADE system, and are provided for each outcome.
The judgements are based on the type of study design
(randomised trials versus observational studies), the risk
of bias, the consistency of the results across studies, and
the precision of the overall estimate across studies. The
recommended approach for assessing risk of bias in
studies involves the use of a two-part tool that addresses
six specific domains, namely, sequence generation and
allocation concealment (selection bias), blinding of par-
ticipants and providers (performance bias), blinding of
outcome assessor (detection bias), incomplete outcome
data (attrition bias), selective outcome reporting (report-
ing bias), and other sources of bias. This provides a rat-
ing of either Low, Medium or High risk of bias. These
ratings use an independent risk of bias score see
Cochrane Handbook for Systematic Reviews of Interven-
tions (Higgins and Green 2011) and the full report for
more details [insert web link to report here].
Results
We identified a total of 5988 records (see Fig. 1). We ac-
quired a total of 181 full-text papers for assessment andFig. 1 PRISMA Flow Diagramexcluded 173 papers; identifying eight eligible trials and
representing 2058 participants. Of the 173 excluded
studies, the main reasons for exclusion were; the study
populations were not offenders (n = 23), they did not
have co-occurring mental health problem (n = 41), the
intervention was not aimed at reducing drug use or
criminal activity (n = 7), the study did not report the re-
quired drug or crime outcome measures at the pre and/
or post-intervention stages (n = 36) and the study did
not report mental health information (n = 16). See the
full report for further details (insert anonymised
reference),
Seven of the eight trials were conducted in the US;
one trial was conducted in Spain. The publications
ranged between 1999 and 2014 with a follow up period
across the studies between 3 months to 5 years. The
treatment length of the interventions (described further
in the review) ranged from 8 weeks (Johnson and Zlot-
nick 2012) to 18 months (Cosden et al. 2003). Seven of
the eight comparisons included adult drug-using of-
fenders with a mean age of 30 years. One study investi-
gated the impact of MI with adolescents aged 14 to
19 years (Stein et al. 2011). Three studies included fe-
male offenders. In all study populations, the majority of
participants were of white ethnic origin.
Four trials represented four different interventions
and five publications: (i) court based sentencing with
acceptance commitment therapy (ACT) and case
management in comparison to treatment as usual
(Cosden et al. (2003); (ii) interpersonal psychotherapy
in comparison to a psychoeducation course (Johnson
and Zlotnick (2012)); (iii) a secure based motivational
interviewing programme in comparison to relaxation
training (Stein et al. (2011) and, (iv) an evaluation of
cognitive behavioural therapy in comparison to ac-
ceptance commitment therapy versus a control group
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2013).
The remaining four trials evaluated different
models of TC intervention. These included (i) a
modified TC in comparison to a combined mental
health and substance use education programme
(Sacks et al. 2004), (ii) a TC (with voluntary after-
care) in comparison to a waiting list control (Pre-
ndergast et al. 2003; Prendergast et al. 2004; Wexler,
et al. 1999), (iii) a female adapted TC compared to
cognitive behavioural therapy, (Sacks et al. 2008),
(iv) a modified TC in comparison to parole supervi-
sion with case management (Sacks et al. 2011). Of
the eight trials, six were conducted in a ‘secure’ set-
ting and two a ‘court’ setting.
Case management
Criminal activity outcomes
Table 2 reports on one trial of 235 participants for the
mental health drug court versus treatment as usual for
self-report criminal activity with a mean follow up of
12 months (Cosden et al. 2003). According to the
GRADE Working Group, the rating of very low suggests
there is uncertainty about the estimate. The assumed
risk of the control group is the probability of engaging
in criminal activity in the comparison group who have
not received the intervention. The RR is slightly higher
than 1, indicating a trend towards the intervention
group being more likely to engage in criminal behaviour
compared to the control group (RR 1.05, 95 % CI 0.90 to
1.22). This single study with a non-significant result
should be interpreted with caution.
Motivational interviewing, cognitive skills and relaxation
training
Drug misuse outcomes
Table 3 shows two outcomes for self-report drug use:
continuous and dichotomous. The continuous outcomeTable 2 Case Management for drug-using offenders with co-occurr
Outcomes Illustrative comparative risks* (95
Assumed risk Corresponding
Control Mental health
Self report dichotomous criminal activity
Follow-up: mean 12 months
Study population
724 per 1000 761 per 1000 (
Moderate
725 per 1000 761 per 1000 (
*The basis for the assumed risk (e.g. the median control group risk across studies) i
interval) is based on the assumed risk in the comparison group and the relative eff
CI confidence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the esti
Moderate quality: Further research is likely to have an important impact on our co
Low quality: Further research is very likely to have an important impact on our con
Very low quality: We are very uncertain about the estimateis represented by one trial (Stein et al. 2011) with 162
participants of low quality as rated by GRADE, for
motivational interviewing and cognitive skills for drug
using offender’s vs relaxation therapy. This quality in-
dicates that further research is likely to impact on the
confidence of the estimate and may change the esti-
mate. The study reported no statistically significant
reduction in self-report drug use (MD −7.42, 95 % CI
−20.12 to 5.28). The dichotomous outcomes were rep-
resented by one trial (Lanza and Gonzalez-Menendez
2013) with 41 participants of very low quality as rated
by GRADE software, for a mean follow up of three
months. The RR is less than 1 indicating a desirable
effect of the intervention in reducing drug use (RR
0.92, 95 % CI 0.36 to 2.33).
Interpersonal psychotherapy
Drug misuse outcomes
Table 4 reports on one trial (Johnson and Zlotnick 2012)
with 38 participants evaluating interpersonal psychother-
apy for drug using offenders, for a mean follow up of
3 months. The assumed risk of the control group is the
probability of drug use (self-report) occurring in the
comparison group who have not received the interper-
sonal psychotherapy intervention. The RR is less than 1,
indicating a desirable effect of having the intervention
for reducing drug use (RR 0.67, 95 % CI 0.3 to 1.5).
Therapeutic community interventions
Criminal activity outcomes
Table 5 reports on two criminal activity outcomes: re-
arrest and re-incarceration for therapeutic community
interventions. Re-arrest is represented by two studies
(Sacks et al. 2008; Wexler, et al. 1999) with a total of 798
participants. The outcome is rated as moderate quality
of evidence by GRADE software, which suggests further
research is likely to impact on the confidence in the esti-
mate of effect. The two studies (Sacks et al. 2008;ing mental illness
% CI) Relative effect
(95 % CI)
No of
Participants
(studies)
Quality of the
evidence
(GRADE)
risk
court
RR 1.05 (0.9 to 1.22) 208 (1 study) ⊕⊝⊝⊝ very low
652 to 884)
652 to 885)
s provided in footnotes. The corresponding risk (and its 95 % confidence
ect of the intervention (and its 95 % CI)
mate of effect
nfidence in the estimate of effect and may change the estimate
fidence in the estimate of effect and is likely to change the estimate
Table 3 Motivational interviewing and cognitive skills for drug-using offenders with co-occurring mental illness
Outcomes Illustrative comparative risks* (95 % CI) Relative
effect
(95 % CI)
No of
Participants
(studies)
Quality of
the
evidence
(GRADE)
Assumed
risk
Corresponding risk
Control Motivational interviewing and cognitive skills
Self report drug use continuous
Follow-up: mean 3 months
– The mean self report drug use continuous in the intervention
groups was 7.42 lower (20.12 lower to 5.28 higher)
– 162 (1
study)
⊕⊕⊝⊝
low
Self report drug use
dichotomous
Follow-up: mean 3 months
Study population RR 0.92
(0.36 to
2.33)
41 (1 study) ⊕⊝⊝⊝
very low
364 per
1000
335 per 1000 (131 to 847)
Moderate
364 per
1000
335 per 1000 (131 to 848)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95 % confidence
interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95 % CI)
CI confidence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate
Very low quality: We are very uncertain about the estimate
Woodhouse et al. Health and Justice  (2016) 4:10 Page 8 of 15Wexler, et al. 1999) showed no statistically significant re-
duction in re-arrest following treatment: (RR 1.65, 95 %
CI 0.83 to 3.28, 370 participants) and (RR 0.96, 95 % CI
0.82 to 1.13, 428 participants) respectively. Three trials
with re-incarceration outcomes represented 636 partici-
pants and are of moderate quality as rated by GRADE
software, with a mean follow up of 12 months. Two of
these three trials reported a statistically significant re-
duction in re incarceration at follow up. Sacks et al.
(2004) compared a personal reflections TC and volun-
tary residential aftercare versus mental health
programme (RR 0.28, 95 % CI 0.13 to 0.63, 139 partici-
pants); and Sacks et al. (2011) compared re-entry modi-
fied TC treatment versus parole supervision case
management (RR 0.49, 95 % CI 0.27 to 0.89, 127 partici-
pants). The third study (Sacks et al. 2008) did not find
statistically significant results comparing a TC program
versus cognitive behavioural intervention (RR 0.73, 95 %
CI 0.45 to 1.19, 370 participants).Table 4 Interpersonal psychotherapy for drug-using offenders with
Outcomes Illustrative comparative risks* (95 % C
Assumed risk Corresponding risk
Control Interpersonal psych
Self report drug use dichotomous
Follow-up: mean 3 months
Study population
474 per 1000 317 per 1000 (142
Moderate
*The basis for the assumed risk (e.g. the median control group risk across studies) i
interval) is based on the assumed risk in the comparison group and the relative eff
CI confidence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the esti
Moderate quality: Further research is likely to have an important impact on our co
Low quality: Further research is very likely to have an important impact on our con
Very low quality: We are very uncertain about the estimateDrug misuse outcomes
Three TC studies reported results for self-report drug
use. One study showed a statistically significant reduc-
tion: Sacks et al. (2004) (RR 0.58, 95 % CI 0.36 to 0.93,
139 participants); the second study found a near statisti-
cally significant reduction: Sacks et al. (2008) (RR 0.73,
95 % CI 0.53 to 1.01, 370 participants); while the third
study found no statistically significant reduction: Wexler,
et al. (1999) (RR 1.11, 95 % CI 0.82 to 1.49, 576
participants).
Secondary outcomes
Identification and type of mental health problem
Mental health diagnoses varied across the studies with a
range of different criteria and assessment mechanisms
(see Table 6). The eight trials reported 17 different men-
tal health diagnoses (e.g., depression, post-traumatic
stress disorder and generalised anxiety disorder). The
most prevalent diagnosis reported in six trials wasco-occurring mental illness
I) Relative effect
(95 % CI)
No of
Participants
(studies)
Quality of the
evidence
(GRADE)
otherapy
RR 0.67 (0.3 to 1.5) 38 (1 study) ⊕⊝⊝⊝ very low
to 711)
s provided in footnotes. The corresponding risk (and its 95 % confidence
ect of the intervention (and its 95 % CI)
mate of effect
nfidence in the estimate of effect and may change the estimate
fidence in the estimate of effect and is likely to change the estimate
Table 5 Therapeutic community for drug-using offenders with co-occurring mental illness
Outcomes Illustrative comparative risks* (95 % CI) Relative effect (95 % CI) No of
Participants(studies)
Quality of the
evidence (GRADE)Assumed risk Corresponding risk
Control Therapeutic community
Criminal activity - Re-arrests
Follow-up: mean 12 months
117/340 (34.4 %) 167/458 (36.5 %) 1st study: 1.65 [0.83, 3.28]
2nd study:0.96 [0.82, 1.13]
798 (2 studies) ⊕⊕⊕⊝ moderate
Criminal activity - Re-incarceration
Follow-up: mean 12 months
71/283 (25.1 %) 47/353 (13.3 %) 1st study:0.28 [0.13, 0.63]
2nd study:0.73 [0.45, 1.19]
3rd study:0.49 [0.27, 0.89]
636 (3 studies) ⊕⊕⊕⊝ moderate
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95 % confidence
interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95 % CI)
CI confidence interval
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate
Very low quality: We are very uncertain about the estimate
Table 6 Mental Health Identification and Diagnoses
Study, year Criteria used for diagnoses Description of mental health problem
Cosden et al. 2003 Determined by a psychiatrist/psychologist
on the basis of a clinical interview
and observations
Mood disorder
Schizophrenia
Bipolar disorder
Other
Dual diagnosis
Johnson and Zlotnick 2012 Hamilton Rating Scale for Depression
Median duration of index episode in months
Number of depressive episodes
Number of previous suicide attempts
DSM-IV Axis I disorders using the SCID-I/II.
Criteria for a major depressive
disorder at least 4 weeks after
substance abuse treatment
Minimum score of 18 on the
Hamilton Rating Scale for Depression.
Lanza and Gonzalez-Menendez 2013 DSM-IV
Mini International Neuropsychiatric Interview
Anxiety Sensitivity Index
Anxiety
Mental health disorders
Antisocial personality disorder
Major depressive disorder
Generalised anxiety disorder
Sacks et al. 2004 DIS Diagnoses of lifetime Axis I or
Axis II mental disorder
Antisocial personality disorder
Sacks et al. 2008 Global Severity Index
Beck Depression Inventory
Lifetime of mental health
PTSD Symptom Scale - Interview
Posttraumatic Stress Diagnostic Scale
Depression
PTSD
Lifetime of mental health
Sacks et al. 2011 DSM-IV diagnostic criteria
Beck Depression Inventory
Post Traumatic Stress Disorder
Symptom Scale
Brief Symptom Inventory
Global Severity Index
Depression
PTSD
Psychological distress
Stein et al. 2011 CES-D Scale Scores >16 indicate presence
of significant depression. 69.8 % had
significant depressive symptoms
Wexler et al. 1999;
Prendergast et al.
2003; Prendergast et al. 2004
Not specified Antisocial personality disorder
Phobias
PTSD
Depression
Dysthymia
Attention deficit hyperactivity disorder
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Gonzalez-Menendez 2013; Sacks et al. 2008, 2011; Stein
et al. 2011; Wexler, et al. 1999). A range of assessment
tools were used to identify the different diagnoses. These
included use of the Anxiety Severity Index (ASI), Beck
Depression Inventory (BDI) and Mini International
Neuropsychiatric Interview (MINI). One study did not
specify the criteria used for diagnoses (Wexler, et al.
1999) and one employed a clinical interview and obser-
vations by a Psychiatrist (Cosden et al. 2003).
In addition to the drug and criminal activity outcomes,
mental health outcomes were reported across the eight
trials. Three trials reported mental health diagnoses at
baseline, but did not report any post treatment mental
health outcomes (Sacks et al. 2004, 2011; Wexler, et al.
1999). One trial reported some mental health outcomes;
but did not provide enough information to enable us to
extract the data (Stein et al. 2011).
Impact on mental health outcome
Four of the eight trials reported on outcomes of mental
health improvement across the intervention and com-
parison/control groups. Johnson and Zlotnick (2012) re-
ported significantly lower Hamilton Depression Scale
scores in the intervention group (interpersonal therapy)
compared to the control group. Three studies evaluating
a TC model, case management and cognitive behavioural
skills showed improvements in scores across both the
intervention and control group. The Sacks et al. (2008)
study evaluating TC showed improvements in mental
health symptoms, assessing using the BDI at 6 months
follow up across both intervention groups. This im-
provement was maintained at 12 months for the TC
group, while the control group continued to improve be-
tween 6 and 12 month follow up. For case management
reductions were reported across both intervention
groups for the number of participants meeting criteria
for mental health diagnoses (including; mood disorder,
schizophrenia, bipolar disorder), determined by a psych-
iatrist/psychologist at 12 months follow up. For cognitive
skills, Lanza and Gonzalez-Menendez (2013) reported
reductions across both the intervention and control
groups for MINI assessed mental health disorders, in-
cluding major depressive disorder and generalised anx-
iety disorder.
Resource information and economical appraisal
Two trials and seven publications provided some re-
source information (McCollister et al. 2003; Prendergast
et al. 2003; Prendergast et al. 2004; Sacks et al. 2011;
Sacks et al. 2004; Sacks et al. 2008; Sacks et al. 2012;
Wexler, et al. 1999). The series of Prendergast studies
presented economic differences when compared to the
one-year TC outcome study. The Prendergast researchsuggests that optimal cost savings appear to require
prison treatment plus aftercare rather than prison treat-
ment alone (McCollister et al. 2003). This was rated as
3B on the Drummond checklist. The series of Sacks TC
publications contained some information about cost, but
not sufficient to conduct a cost-effectiveness appraisal
(Sacks et al. 2004). This was rated on the Drummond
checklist as 3A. The authors of this study noted the add-
itional marginal costs (on top of the specific incarcer-
ation costs) were $7.37 per day, versus $148.19 cost of a
prison day. This suggests a substantial cost saving sup-
porting the use of TC programmes over prison.
Discussion
Summary of main results
This systematic review provided evidence from eight tri-
als. The trials were conducted in secure and court set-
tings. We do not have sufficient evidence to be able to
suggest whether these interventions work better in one
setting as opposed to another. Five different types of
treatment interventions were identified. These included:
case management, motivational interviewing and cogni-
tive skills, interpersonal psychotherapy and TC models.
Outcomes of criminal activity and drug use
The TC studies reported statistically significant reduc-
tions in subsequent re-incarceration, but not for re-
arrest. This finding could be an artefact of the type of
outcome. Incarceration (or re-incarceration) to prison
takes longer to process and often involves a court case
which means that it is likely to be recorded within the
time frame of an experimental evaluation. In compari-
son, ‘arrest’ (or ‘re-arrest’) is more frequent and is re-
corded in the CJS within a shorter time frame. Sacks
et al. (2011) also argues that participation in a treatment
option does not necessarily lead to less involvement with
the CJS, but success might instead be a reduction in the
severity of the offence committed such that re-
incarceration is less likely. The follow-up studies to the
Wexler trial also commented on differential effectiveness
of treatment outcomes (Prendergast et al. 2003, 2004;
Wexler, et al. 1999). The authors argue that focusing on
only one or two outcomes may mask the impact of treat-
ment on other outcome domains that are of interest to
various stakeholders. For example, measuring re-arrest
or re-incarceration does not reveal the reason for why
an individual has returned to correctional supervision.
Unanswered questions include (i) the length of time an
offender remains in the community until re-arrest, (ii)
knowledge about what crimes are committed, and (iii)
the reasons for return.
One specifically adapted TC treatment for women of-
fenders compared women assigned to TC treatment or
standard treatment, a cognitive behavioural recovery and
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as the Intensive Outpatient Program (Sacks et al. 2008).
At 6 months the study found that both groups improved
significantly on variables of mental health, substance
use, criminal behaviour, and HIV risk. The authors note
that further exploration of each model for different of-
fender groups is required to permit a precise utility of
each model. The authors concluded that the preliminary
findings demonstrate the importance of providing
gender-specific sensitive and comprehensive approaches
within the correctional system (Sacks et al. 2008). The
more recent follow-up study investigated outcomes at 6
and 12 months. The outcomes followed a similar pat-
tern, with both groups of women benefiting from treat-
ment. TC treatment was found to be more beneficial
than cognitive behavioural therapy at improving re-
incarceration rates and lengthening the amount of time
spent in the community before subsequent re-
incarceration (Sacks et al. 2008).
We noted no statistically significant reductions for
criminal activity or self-report drug use with the use of
case management via a mental health court; Motiv-
ational interviewing with cognitive skills over relaxation
training; and Acceptance and Commitment Therapy
(ACT) or interpersonal psychotherapy (Cosden et al.
2003; Johnson and Zlotnick 2012; Lanza and Gonzalez-
Menendez 2013; Stein et al. 2011). The interpersonal
psychotherapy was evaluated using a pilot study of
women suffering from major depression and substance
use disorder (Johnson and Zlotnick 2012). This feasibil-
ity trial was used to assess the applicability of using
interpersonal psychotherapy in a prison environment.
The findings showed that participants undergoing inter-
personal psychotherapy had significantly reduced levels
of depression and substance misuse over the attention-
matched control (Johnson and Zlotnick 2012).
The study evaluating ACT in comparison to trad-
itional cognitive behavioural therapy found higher
levels of abstinence in the ACT (43.8 %) when com-
pared to the control (18.2 %). These findings are
similar to other studies that have used ACT albeit in
non-incarcerated populations (Hayes et al. 2004). The
authors attribute the success of ACT to the nature of
the’co-joint’ work between the therapist and client,
which aims to increase the flexibility and structure of
the therapy allowing the client to have greater auton-
omy over decision-making. They argue that cognitive
behavioural therapy is more systematically directed by
the therapist, leaving little scope for responsive
change (Lanza et al. 2014; Lanza and Gonzalez-
Menendez 2013). In summary, each study represented
a singular trial and caution is called for in interpret-
ing the results of the studies as further research is
likely to change the impact of confidence.Mental health information
In terms of addressing some of the complex issues of in-
dividuals with mental health problems and co-occurring
substance abuse, the evidence from this systematic re-
view provides starting point for further discussion. Three
studies discussed the differential treatment effects on the
severity of depression (Cosden et al. 2003; Johnson and
Zlotnick 2012; Stein et al. 2011). The Cosden et al.
(2003) study noted further understanding of how to help
clients with a serious mental health problem with differ-
ent levels of treatment is needed. The Johnson and Zlot-
nick (2012) study noted that participants undergoing
interpersonal psychotherapy had significantly reduced
levels of depression and substance misuse over the
attention-matched control. The authors noted that treat-
ment intensity for the individual once released was one
key factor to maintaining good outcomes. However, they
go on to state that women often experience delays in
treatment and service provision on release, and they sug-
gest that alternative service provision such as phone
treatment might be helpful in providing a more intensive
post-release treatment and useful in times of crisis
(Johnson and Zlotnick 2012).
Study descriptions of mental ill health varied (see
Table 5). The Cosden et al. (2003) study used a Psych-
iatrist or Psychologist to conduct a clinical interview to
make a mental health diagnosis alongside substance mis-
use. This resulted in a mental health court sample of in-
dividuals diagnosed with a range of mental health
problems including mood disorder, schizophrenia, bipo-
lar disorder, and dual diagnosis. Other papers referred to
use of the DSM-IV diagnostic criteria (Sacks et al. 2011),
but subsequently provided little information with
regards to individual mental health needs. Demographic
information in the Sacks et al. 2004 study reported on
other aspects of mental health prognosis, including life-
time mental health treatment, lifetime in patient care,
and prescribed medication (Sacks et al. 2004). The Wex-
ler series of studies reported a range of diagnoses, in-
cluding antisocial personality disorder, phobias, post-
traumatic stress disorder, depression, dysthymia, and at-
tention deficit disorder, but did not describe how these
diagnoses were confirmed or assessed within the
population.
Six trials reported on change in mental health well-
being. Three trials used the Beck Depression Inventory,
Global Severity Index, and the Posttraumatic Diagnostic
Scale (Sacks et al. 2004, 2008, 2011). Another study re-
ported on Depression but used the Hamilton Rating
Scale for Depression (Johnson and Zlotnick 2012). Two
studies reported presence of mood disorder alongside
schizophrenia, general anxiety disorder, and antisocial
personality disorder (Cosden et al. 2003; Lanza et al.
2014; Lanza and Gonzalez-Menendez 2013). Reporting
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cluded studies. Three studies reported baseline data but
did not provide follow up mental health outcomes
(Sacks et al. 2004, 2011; Wexler, et al. 1999) and one
study did not provide mental health data in a usable for-
mat (Stein et al. 2011). The remaining studies provided
mental health data pre and post intervention, however
each of the four studies administered a different assess-
ment tool, including BDI, Hamilton Depression Rating
Scale, and clinician diagnosed, making it difficult to
compare. Future updates of this review will include
mental health outcomes in order to assess the impact of
treatment on mental health well-being alongside crimin-
ality and drug use.
Several successful treatment elements were reported
throughout the included trials. First, we noted the issue of
treatment engagement as important. In the mental health
court trial, informal support from family and friends en-
couraged the engagement of clients within the community
for longer term gains (Cosden et al. 2003). Second, pro-
grammes that were specifically adapted to the needs of
mental health clients tended to include a cognitive behav-
ioural therapy that emphasised criminal thinking and be-
haviour alongside psycho-educational classes. The
combination of these mechanisms enhanced an individ-
ual’s ability to recognise and understand their substance
misuse and mental health problems in more detail (Sacks
et al. 2004). Third, the longer an individual is engaged in
treatment the better the outcome(s) (Wexler, et al. 1999).
Overall completeness and applicability of evidence
The applicability of the evidence is hindered by the lack
of trial coverage to a range of limited treatment options.
The limited trials were conducted in the US judicial sys-
tem, and are therefore, restricted in their generalisation
to other CJS outside of the US. The current evidence
suggests that TC treatments reduce re-incarceration
rates. The review only identifies measures of self-report
drug use and must be interpreted with caution. In
addition, we can say nothing about whether the treat-
ments are effective in reducing drug use and subsequent
criminal behaviour while offenders are on parole or on
probation in the community.
Resource information
Resource and cost information within the studies was
evident in two studies, allowing for some comparison of
resource information between TC models however both
were considered partial evaluations using the Drum-
mond checklist. Regular report of effect sizes would aid
calculations for power analysis and provide estimates of
the magnitude of treatment effect needed for cost-
benefit and cost-effectiveness analysis and would aid de-
cision making for policy makers.The trial quality
The available evidence was hindered by the lack of trial
coverage to a range of limited treatment options. The
trials were conducted in the US judicial system, and are
therefore, restricted in their generalisation too other CJS
outside of the US. The current evidence suggests that
TC treatments reduce re-incarceration rates. The review
only identifies measures of self-report drug use and must
be interpreted with caution. In addition, we can say
nothing about whether the treatments are effective in re-
ducing drug use and subsequent criminal behaviour
while offenders are on parole or on probation in the
community.
The evidence was often poorly described which pre-
vented the reviewers from making a clear judgement
of bias. The imprecision of reporting lowers the qual-
ity of evidence, which means that further research is
likely to have an impact on our confidence in the es-
timate of effect. Limitations were described relating to
the study design (and leading to problems of selection
bias), and in some studies sample sizes were small.
The Stein et al. (2011) study was noted as being rela-
tively underpowered and replication of the study is
required to enhance the generalisation and external
validity of the study findings. Similar modest sample
sizes were reported by Sacks et al. (2011); Cosden
et al. (2003), who suggested that larger samples
should be used to provide a more precise estimate of
effect. The Cosden study also reported on the possi-
bility of outcome bias, as the interviewer was not
blind to the outcome condition of the participant,
and loss to follow-up (25 % of the study sample were
lost to follow-up) at 12 months (Cosden et al. (2003).
Another possible selection bias concern in the series
of Wexler studies was that participants were randomly
assigned to the prison TC treatment and regular prison
conditions but not to aftercare (Prendergast et al. 2003,
2004; Wexler, et al. 1999). The authors noted that pos-
sible differences in personal motivation may account for
some of the positive outcomes associated with partici-
pants’ continued support for aftercare services. Subse-
quently these participants were noted as having the
highest’readiness scores’, which suggests that motivation
creates an important consideration on client selection
(Wexler, et al. 1999).
Implications for research
We have identified several research implications. First,
good-quality research is required to evaluate the effect-
iveness of interventions in offenders with substance mis-
use problems and co-occurring mental health problems.
Of particular interest are the extended long-term effects
of aftercare and the level of contact required with ser-
vices in the community. Further research to enhance to
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alternatives following release may help to unravel this
process. Second, better descriptions of participants’
mental health problems and more detailed informa-
tion about mental health diagnoses are required to
enable the transferability of information to clinical
practice. Such information could also facilitate the
use of mental health diagnoses as a moderator within
the analysis of the outcomes. Third, trial interventions
specifically focusing on females and adolescents are
required. In the current review one study contained
females, and one study reported on adolescents.
Fourth, little is known about the interaction between
mental health problems, individual personal character-
istics and positive outcomes relating to treatment suc-
cess. In terms of depression, Stein et al. (2011)
attempted to explore some of the differences between
participants with few and with many depressive symp-
toms. Future studies should consider an analysis of
existing datasets to reveal which individuals with
which mental health diagnosis fair better than others,
enabling improved targeting of resources.
Finally, standardising cost and cost-effectiveness infor-
mation within trial evaluations would help policymakers
make decisions about health versus criminal justice
costs. New outcome evaluations should consider the
length of time to a parolee’s re-arrest or re-
incarceration, as this has cost implications. For example,
the Prendergast et al. (2003) study found that commu-
nity residential treatment kept parolees from relapse or
recidivism so long as they remained in treatment. Such
evaluations provide potential important information for
stakeholders and funding bodies involved in distributing
budgets to fund such enterprises.
Conclusions
Two studies employing therapeutic community interven-
tions with aftercare showed a reduction in subsequent
re-incarceration. However, the studies generally showed
a high degree of variation, warranting a degree of cau-
tion in the interpretation of the magnitude of effect and
direction of benefit for treatment outcomes. More evalu-
ations are required to assess the effectiveness of inter-
ventions for drug-using offenders with co-occurring
mental health problems with better mental health de-
scriptions and outcome measurement.
Endnotes
1Cochrane Central Register of Controlled Trials (CEN-
TRAL) (1980 to April 2014), MEDLINE (1966 to April
2014), EMBASE (1980 to April 2014), PsycINFO (1978 to
April 2014), PASCAL (1973 to November 2004)a, Sci-
Search (Science Citation Index) (1974 to April 2014), So-
cial SciSearch (Social Science Citation Index) (1972 toApril 2014), ASSIA (1987 to April 2014), Wilson Applied
Science and Technology Abstracts (1983 to October
2004)a, Inside Conferences (1993 to November 2004)a,
Dissertation Abstracts (1961 to October 2004)a, NTIS
(1964 to April 2014), Sociological Abstracts (1963 to April
2014), HMIC (to April 2014), PAIS (1972 to April 2014),
SIGLE (1980 to June 2004)b, Criminal Justice Abstracts
(1968 to April 2014), LILACS (2004 to April 2014), Na-
tional Research Register (March 2004)c Current Con-
trolled Trials (December 2009), DrugScope (February
2004) - unable to access, SPECTRA (March 2004)d.
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